lunes, 13 de noviembre de 2017

Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients. - PubMed - NCBI

Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients. - PubMed - NCBI



 2017 Oct;177(4):901-902. doi: 10.1111/bjd.15886.

Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients.


PMID:
 
29052902
 
PMCID:
 
PMC5679270
 [Available on 2018-10-01]
 
DOI:
 
10.1111/bjd.15886

[Indexed for MEDLINE]

No hay comentarios:

Publicar un comentario